ACADIA Pharmaceuticals Inc. (ACAD) Lifted to "Hold" at ValuEngine

ACADIA Pharmaceuticals Inc. (ACAD) Lifted to

ACADIA Pharmaceuticals has an average rating of Buy and an average price target of $43.23. Moving out to look at the previous month volatility move, the stock is at 1.94%.

Several research analysts have issued reports on the stock. Wedbush maintained the stock with "Outperform" rating in Friday, July 29 report. Piper Jaffray has "Neutral" rating and $48.0 target. Massmutual Fsb Adv has invested 0% in ACADIA Pharmaceuticals Inc. Vetr has "Hold" rating and $51.38 target.

08/08/2016 - ACADIA Pharmaceuticals Inc. had its "buy" rating reiterated by analysts at JMP Securities. Fincl Architects has invested 0.01% in ACADIA Pharmaceuticals Inc. ACADIA Pharmaceuticals had 22 analyst reports since August 7, 2015 according to SRatingsIntel. (NASDAQ:ACAD) Performing Well? As per Friday, April 28, the company rating was maintained by Maxim Group. The stock of ACADIA Pharmaceuticals Inc. Venbio Select Advisor LLC claims 614,200 shares with a value of $17,130,000. The value of the investment in ACAD increased from $94,668,000 to $117,539,000 a change of 24.2% since the last quarter. Acadia Pharmaceuticals now has $4.32B valuation. ACAD has diverse figures for different time frames; starting from week's performance it has positive performance of 5.26% in last five regular trading sessions. About 14 shares traded.

Investors sentiment decreased to 1.05 in Q4 2016. Its down 0.06, from 1.11 in 2016Q3. 119.51 million shares or 2.68% more from 116.39 million shares in 2016Q3 were reported. Fred Alger Mngmt reported 0.31% of its portfolio in ACADIA Pharmaceuticals Inc.

Separately, Executive Vice President Glenn Baity unloaded 38,097 stocks of the company's shares in a trade that took place on Thurs, Jul 20th. Da Davidson & Company holds 0% or 630 shares in its portfolio. Blackrock Invest Mngmt Limited Liability Corporation owns 0% invested in ACADIA Pharmaceuticals Inc. It also reduced Celgene Corp (NASDAQ:CELG) stake by 48,137 shares and now owns 433,981 shares. Employees Retirement Association Of Colorado owns 21,405 shares. Manufacturers Life Insur The holds 0% or 10,597 shares. (NASDAQ:ACAD)'s near-term growth potential.

11/11/2016 - Goldman Sachs began new coverage on ACADIA Pharmaceuticals Inc. giving the company a "neutral" rating. (NASDAQ:ACAD). Hightower Advsr invested in 0% or 9,196 shares.

08/05/2016 - ACADIA Pharmaceuticals Inc. was downgraded to "hold" by analysts at Aegis Capital. (NASDAQ:ACAD) for 36,171 shares. (NASDAQ:ACAD). Lpl Limited Liability Corporation invested in 23,705 shares.

ACADIA Pharmaceuticals Inc., launched on January 16, 1997, is a biopharmaceutical company. The company had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.36 billion. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. It now has negative earnings. Its lead drug candidate, NUPLAZID (pimavanserin), is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PD Psychosis).

The stock increased 1.54% or $0.55 on September 1, reaching $36.16.

Recently analysts working for various investment brokerages have changed their ratings and price targets on shares of ACADIA Pharmaceuticals Inc. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has declined 15.19% since September 5, 2016 and is downtrending. It has underperformed by 31.89% the S&P500. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. Therefore 63% are positive. The firm has "Buy" rating by Jefferies given on Thursday, July 27. The rating was maintained by Needham on Monday, June 19 with "Sell". RSI is a technical indicator of price momentum, comparing the size of recent gains to the size of recent losses and establishes oversold and overbought positions. The firm has "Market Perform" rating given on Tuesday, May 3 by Leerink Swann. Oppenheimer has "Hold" rating and $14800 target. Sterne Agee CRT initiated the shares of SYK in report on Wednesday, November 4 with "Neutral" rating. The shares were purchased at an average price of $30.00. The insider Scannell Timothy J sold 13,322 shares worth $1.81M. With 1,900 avg volume, 0 days are for Servotronics Incorporated (NYSEMKT:SVT)'s short sellers to cover SVT's short positions.

Investors sentiment decreased to 0.85 in Q4 2016. It dropped, as 50 investors sold SYK shares while 331 reduced holdings. 26 funds opened positions while 74 raised stakes. 318,832 shares or 2.73% more from 310,364 shares in 2016Q3 were reported. Ingalls And Snyder Lc invested 0.02% in Spectra Energy Partners, LP (NYSE:SEP). Sandy Spring National Bank & Trust, a Maryland-based fund reported 1,500 shares. Morgan Stanley has 0% invested in Servotronics, Inc. State Of New Jersey Common Pension Fund D reported 85,900 shares stake. Parametrica Management accumulated 18,223 shares. It also upped Novartis (NYSE:NVS) stake by 34,314 shares and now owns 67,214 shares. State Of Wisconsin Investment Board holds 55,226 shares.

Like this


07 September 2017
Carl Frampton confirms Jamie Moore as new trainer after split from McGuigans
Today Frampton confirmed that Moore, who has worked with Tommy Coyle and Matthew Macklin, would take over training duites. Frampton has not yet unveiled who will be his new promoter after ditching Barry McGuigan's Cyclone Promotions.

07 September 2017
Priceline Com Inc (NASDAQ:PCLN) Institutional Investor Sentiment Is 0.94
Clint Murray decreased its stake in Wabco Hldgs Inc (WBC) by 12.22% based on its latest 2016Q4 regulatory filing with the SEC. The business services provider reported $15.14 EPS for the quarter, beating the Zacks' consensus estimate of $14.25 by $0.89.

07 September 2017
Gamestop Corporation (GME) Ex-Dividend Date Scheduled for September 07, 2017
Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. The Fund provides high current income as a primary objective and capital appreciation as a secondary objective.

07 September 2017
Supreme Court asks government for detailed reply on deportation of Rohingyas
That also applies equally to Rohingyas who have settled in different parts of the country, including Jammu and Kashmir. Rijiju said that India will not use force for deportation, rather will follow legal procedures.

07 September 2017
Teleflex Inc (NYSE:TFX) Q4 2016 Sentiment
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. The stock has a market capitalization of $9.50 billion, a price-to-earnings ratio of 40.34 and a beta of 1.05.

07 September 2017
Kobo launches new iOS and Android audiobook marketplace
The audiobooks and eBooks can be found and purchased within Kobo's iOS and Android apps. Kobo is also offering rewards called Super Points that can be applied toward audiobooks.

07 September 2017
PSG didn't respect my true worth - Aurier
In terms of statistics, of all defenders of the French Ligue 1 championship, from 2013 until today, I am the most decisive. I rejected that, for various reasons. "I now have to fight, progress and live great moments with my new club".

07 September 2017
'Mean Girls' Musical Sets A Broadway Premiere Date!
Entertainment Weekly has shared a first look at "The Plastics" from the Broadway-bound production of Mean Girls . The film, which was released in 2004 (yes - 13 years ago) was big for stars Lindsay Lohan and Rachel McAdams .

07 September 2017
Carlson Capital Management Acquires 69 Shares of Target Co. (NYSE:TGT)
Several analysts have released their opinion on Target Corporation (NYSE:TGT), with 3 analysts believing it is a strong buy. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website .

07 September 2017
Helen of Troy Limited (HELE) Holdings Increased by Arizona State Retirement System
Teacher Retirement System of Texas bought a new position in shares of Helen of Troy Limited in the first quarter worth $209,000. The Company is a global designer, developer, importer, marketer and distributor of a portfolio of brand-name consumer products.